Search results for " Seconda"

showing 10 items of 975 documents

Occupation, education, and Parkinson's disease: A case-control study in an Italian population

1996

Current epidemiologic data on the association between occupational exposures and Parkinson's disease (PD) are inconsistent. In a case-control study, we investigated the associations between occupation and PD and between education and PD. The cases (n = 62) were those identified in a prevalence survey (door-to-door, two-phase) of three Sicilian municipalities, as a November 1, 1987. We then randomly selected from the general population two controls for each case, matched for age ( +/- year), sex, and municipality (n = 124). Information on current and past occupations and education for cases and controls was obtained during the survey. Subjects who worked for most of their lives as farmers we…

AdultMalemedicine.medical_specialtyParkinson's diseasePopulationOccupational diseaseDiseaseRisk FactorsOccupational ExposureEpidemiologyHumansMedicineParkinson Disease SecondaryRisk factoreducationAgededucation.field_of_studybusiness.industryCase-control studyAgricultureMiddle Agedmedicine.diseaseItalian populationAgricultural Workers' DiseasesOccupational DiseasesItalyNeurologyCase-Control StudiesEducational StatusFemaleNeurology (clinical)businessDemographyMovement Disorders
researchProduct

How increased pertussis vaccination coverage is changing the epidemiology of pertussis in Italy.

2005

Abstract The epidemiology of pertussis in Italy is described by using data from the statutory notification system and from seroepidemiology studies. Starting from the 1990s, the incidence of pertussis in Italy has shown a sharp decline and is now at the lowest level ever reached. During this time period vaccination coverage has increased from 88% in 1998 to 95% in 2003. In 1996–97, the prevalence of subjects with levels of IgG antibodies against PT greater than 2 EU/ml was 77.6%. The increase in vaccination coverage will probably change the pattern of disease transmission and increase the number of susceptible adults, unless administration of booster doses to adolescents and adults is consi…

AdultMalemedicine.medical_specialtyPediatricsAdolescentWhooping CoughImmunization SecondaryMandatory ProgramsMass VaccinationPertussiSeroepidemiologic StudiesEpidemiologyMedicineHumansPertussis vaccinationRegistriesChildWhooping coughSeroepidemiologyVaccination coveragePertussis VaccineBooster (rocketry)General VeterinaryGeneral Immunology and Microbiologybusiness.industryIncidence (epidemiology)Public Health Environmental and Occupational HealthAge FactorsInfantmedicine.diseaseAntibodies BacterialInfectious DiseasesItalyVaccination coverageChild PreschoolPopulation SurveillanceImmunologyMolecular MedicineFemalebusinessTos ferinaDisease transmissionVaccine
researchProduct

Multisensorial Perception in Chronic Migraine and the Role of Medication Overuse.

2020

Multisensory processing can be assessed by measuring susceptibility to crossmodal illusions such as the Sound-Induced Flash Illusion (SIFI). When a single flash is accompanied by 2 or more beeps, it is perceived as multiple flashes (fission illusion); conversely, a fusion illusion is experienced when more flashes are matched with a single beep, leading to the perception of a single flash. Such illusory perceptions are associated to crossmodal changes in visual cortical excitability. Indeed, increasing occipital cortical excitability, by means of transcranial electrical currents, disrupts the SIFI (ie, fission illusion). Similarly, a reduced fission illusion was shown in patients with episod…

AdultMalemedicine.medical_specialtygenetic structuresmedia_common.quotation_subjectMigraine DisordersIllusionSound-induced flash illusionTriptansAudiologyAffect (psychology)03 medical and health sciencesYoung Adult0302 clinical medicineChronic Migraine030202 anesthesiologyPerceptionmedicineHeadache Disorders Secondaryaudio-visual fissionHumansPrescription Drug Overusemedia_commonCrossmodalbusiness.industryaudio-visual fusionPerspective (graphical)Middle Agedmedicine.diseaseIllusionsAnesthesiology and Pain MedicineNeurologyMigraineChronic DiseaseCortical ExcitabilityAuditory PerceptionVisual Perceptionmedication overuse headacheFemaleNeurology (clinical)chronic migrainebusiness030217 neurology & neurosurgeryPsychomotor Performancemedicine.drugThe journal of pain
researchProduct

Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine administered according to an alternative dosing schedule compared wit…

2011

BACKGROUND: The human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine is immunogenic, has a clinically acceptable safety profile, and prevents incident and persistent HPV-16/18 infection and cervical precancerous lesions. This study (NCT00552279) evaluated the vaccine when administered according to an alternative dosing schedule (0-1-12 months) compared with the standard dosing schedule (0-1-6 months). METHODS: The study was of randomized open design and was conducted at multiple centers in Europe. Healthy women aged 15 to 25 years were randomized (1:1) to receive HPV-16/18 vaccine according to the standard schedule at months 0, 1, and 6 (n = 401) or an alternative schedule at months 0, …

AdultMicrobiology (medical)medicine.medical_specialtyScheduleAdolescentImmunization SecondaryEnzyme-Linked Immunosorbent AssayAntibodies Virallaw.inventionYoung AdultAdjuvants ImmunologicRandomized controlled triallawInternal medicinemedicineHumansPapillomavirus VaccinesDosingHuman papillomavirusYoung adultbusiness.industryImmunogenicityhuman papillomavirus human papillomavirus vaccines adolescent immunology alternative dosing scheduleVaccinationvirus diseasesSettore MED/40 - Ginecologia E Ostetriciafemale genital diseases and pregnancy complicationsEuropeSafety profileInfectious DiseasesImmunizationPediatrics Perinatology and Child HealthImmunologyFemalebusiness
researchProduct

Whooping cough, twenty years from acellular vaccines introduction

2015

Clinical pertussis resulting from infection with B. pertussis is a significant medical and public health problem, despite the huge success of vaccination that has greatly reduced its incidence. The whole cell vaccine had an undeniable success over the last 50 years, but its acceptance was strongly inhibited by fear, only partially justified, of severe side effects, but also, in the Western world, by the difficulty to enter in combination with other vaccines: today multi-vaccine formulations are essential to maintain a high vaccination coverage. The advent of acellular vaccines was greeted with enthusiasm by the public health world: in the Nineties, several controlled vaccine trials were car…

AdultPertussis VaccineAcellular vaccinesSecondaryVaccinesSettore MED/07 - Microbiologia E Microbiologia ClinicaTime FactorsAdolescentWhooping CoughMedicine (all)VaccinationImmunization SecondaryVaccine trialInfantVaccines AcellularImmunoprotectionPertussiPertussisAcellularItalyHumansAcellular vaccines; Immunoprotection; Pertussis; Vaccine trials; Adolescent; Adult; Humans; Immunization Secondary; Infant; Italy; Pertussis Vaccine; Time Factors; Vaccination; Vaccines Acellular; Whooping CoughImmunizationVaccine trialsAcellular vaccine
researchProduct

Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis

2022

PURPOSE: To describe data on epidemiology, microbiology, clinical characteristics and outcome of adult patients admitted in the intensive care unit (ICU) with secondary peritonitis, with special emphasis on antimicrobial therapy and source control. METHODS: Post hoc analysis of a multicenter observational study (Abdominal Sepsis Study, AbSeS) including 2621 adult ICU patients with intra-abdominal infection in 306 ICUs from 42 countries. Time-till-source control intervention was calculated as from time of diagnosis and classified into 'emergency' ( 6 h). Relationships were assessed by logistic regression analysis and reported as odds ratios (OR) and 95% confidence interval (CI). RESULTS: The…

AdultSecondary peritonitiCritical IllnessPeritonitisCritical Care and Intensive Care MedicineAnti-Bacterial AgentsAntimicrobial therapyIntensive Care UnitsSecondary peritonitisIntra-abdominal infectionAnti-Infective AgentsRisk FactorsSource controlSepsisMedicine and Health SciencesHumansIntraabdominal InfectionsMortalityRetrospective StudiesAntimicrobial therapy; Intra-abdominal infection; Mortality; Secondary peritonitis; Source controlIntensive Care Medicine
researchProduct

The 2014 lifetime immunization schedule approved by the Italian scientific societies. Italian Society of Hygiene, Preventive Medicine, and Public Hea…

2014

AdultSecondaryAdolescentAdolescent; Adult; Age Factors; Aged; Child; Child Preschool; Humans; Immunization Secondary; Infant; Infant Newborn; Italy; Middle Aged; Societies Medical; Vaccination; Vaccines; Young Adult; Immunization ScheduleImmunization SecondaryYoung AdultMedicalHumansAge FactorPreschoolChildImmunization ScheduleSocieties MedicalAgedVaccinesVaccinationAge FactorsInfant NewbornInfantMiddle AgedNewbornSettore MED/38ItalyChild PreschoolImmunizationSocietiesVaccineHuman
researchProduct

Pneumococcus infections: Is the burden still as heavy?

2012

EA MERS CT3 Enjeu 3; International audience; The death rate of invasive pneumococcal infections decreased by 100 fold in one century. This tremendous improvement was due mainly to antibiotic use and multiple attempts at antipneumococcal vaccinations; thus, this was true only for developed countries. However, in France, the incidence has increased, over the last 10 years, in all age classes except for children vaccinated by the heptavalent pneumococcal conjugate vaccine. The incidence of these infections remains high, when associated to some risk factors such as HIV infection, malignant blood diseases, solid cancers, bronchial diseases, or alcohol abuse. The pneumococcal vaccine should be pr…

AdultSerotypeHeptavalent Pneumococcal Conjugate Vaccine[SDV]Life Sciences [q-bio]Immunization SecondaryAlcohol abuseGlobal HealthPneumococcal InfectionsPneumococcal Vaccines03 medical and health sciences0302 clinical medicineRisk FactorsHeptavalent Pneumococcal Conjugate Vaccine[SDV.BV]Life Sciences [q-bio]/Vegetal BiologyHumansMedicineserotype030212 general & internal medicineSerotypingChildinfection invasive à pneumocoque0303 health sciences030306 microbiologybusiness.industrypneumococcal invasive infectionDeveloped CountriesIncidenceMortality rateIncidence (epidemiology)VaccinationAge Factorssérotypemedicine.disease3. Good healthVaccinationPneumococcal infectionsStreptococcus pneumoniaeInfectious DiseasesPneumococcal vaccine[SDE]Environmental SciencesImmunologyDisease SusceptibilityFrancebusinessMédecine et Maladies Infectieuses
researchProduct

Anti-diphtheria antibody seroprotection rates are similar 10 years after vaccination with dTpa or DTPa using a mathematical model

2003

The reduced antigen content diphtheria, tetanus and pertussis (dTpa) vaccine (Boostrixtrade mark) has been shown to induce a strong booster response to all the vaccine components in 4-6 year olds. However, anti-diphtheria antibody levels were observed to be lower when compared to the "full strength" paediatric DTPa vaccine. To assess the impact of this difference on long-term protection, a mathematical model was developed to predict diphtheria antibody decay over time. The model was based on a linear decrease in log-transformed antibody concentrations after the first year post-vaccination. When applied to data collected 3.5 years after vaccination of 4-6 year olds with either DTPa or dTpa, …

AdultTime Factorsanimal diseasesImmunization SecondaryModels Biologicalcomplex mixturesCohort StudiesAntigenmedicineHumansChildDiphtheria-Tetanus-Pertussis VaccineImmunization ScheduleRandomized Controlled Trials as TopicBooster (rocketry)General VeterinaryGeneral Immunology and MicrobiologybiologyTetanusbusiness.industryDiphtheriaVaccinationPublic Health Environmental and Occupational HealthDiphtheriarespiratory systemmedicine.diseaseAntibodies BacterialVaccinationInfectious DiseasesImmunizationChild PreschoolImmunologycardiovascular systembiology.proteinMolecular MedicineAntibodybusinessDiphtheria antibodycirculatory and respiratory physiologyVaccine
researchProduct

Reklāma kā tēma kulturoloģijā

2019

Diplomdarba tēma - Reklāma kā tēma kulturoloģijā. Pētījuma ievadā pamatota temata izvēle un aktualitāte, kas balstās uz jauniešu izglītošanu par reklāmas būtību un tās lomu sabiedrības vērtību sistēmas ietekmēšanā, uzskatu veidošanā. Darbā izpētīta teorētiskā informācijas bāze par reklāmu. Izpētītas un sistematizētas reklāmas definīcijas, mērķi, veidi un uzdevumi, aplūkota reklāmas vēsturiskā attīstība no pirmsākumiem līdz tās jaunajai realitātei digitālajā laikmetā, sniegts ieskats reklāmas ētikā, aplūkojot tās lomu mūsdienu patērējtājsabiedrībā, apskatīti svarīgākie reklāmas psiholoģijas aspekti un to ietekme uz sabiedrības un indivīda apziņu. Pētījumā apzināti reklāmas izpētes un veidoša…

AdvertisingPedagoģijaPsychology of AdvertisingEthics of AdvertisingAdvertising as a theme in secondary school curriculum
researchProduct